Literature DB >> 15018892

Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms.

Jack L Arbiser1.   

Abstract

A large number of oncogenes, tumor suppressor genes, and signal transduction pathways have been described. Currently, a framework that allows prediction of tumor behavior based upon oncogenes, tumor suppressors, and signal transduction pathways is lacking. In 1869, Mendeleev published a periodic table of elements which allowed prediction of properties of elements based upon atomic weights that allowed prediction of chemical and physical properties of elements yet to be discovered. In this paper, I will discuss recurrent patterns of synergy found in the literature and our laboratory between tumor suppressor genes, oncogenes, and signaling pathways that allows one to predict the signaling pathway in a given tumor based upon the inactivation of a tumor suppressor gene. These patterns can be found in multiple different human neoplasms. Conversely, one can predict the inactivation of a tumor suppressor based upon the activation status of a signaling pathway. This knowledge can be used by a clinician or pathologist with access to immunohistochemistry to make predictions based upon simple technologies and determine the signaling pathways involved in a patient's tumor. These strategies may be useful in the design of prevention and treatment strategies for cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018892     DOI: 10.1016/j.semcancer.2003.09.013

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  12 in total

1.  Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.

Authors:  Francesca Cerimele; Traci Battle; Rebecca Lynch; David A Frank; Emma Murad; Cynthia Cohen; Nada Macaron; John Sixbey; Kenneth Smith; Randolph S Watnick; Aristidis Eliopoulos; Bahig Shehata; Jack L Arbiser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

2.  RGS-GAIP-interacting protein controls breast cancer progression.

Authors:  Ling Wang; Julie S Lau; Chitta Ranjan Patra; Ying Cao; Santanu Bhattacharya; Shamit Dutta; Debashis Nandy; Enfeng Wang; Chamila N Rupasinghe; Pawan Vohra; Mark R Spaller; Debabrata Mukhopadhyay
Journal:  Mol Cancer Res       Date:  2010-10-27       Impact factor: 5.852

3.  Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo.

Authors:  Sulochana S Bhandarkar; Jacqueline Bromberg; Carol Carrillo; Ponniah Selvakumar; Rajendra K Sharma; Betsy N Perry; Baskaran Govindarajan; Levi Fried; Allie Sohn; Kalpana Reddy; Jack L Arbiser
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

Review 4.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

5.  Differential effects of specific amino acid restriction on glucose metabolism, reduction/oxidation status and mitochondrial damage in DU145 and PC3 prostate cancer cells.

Authors:  Xiaoyi Liu; Ya-Min Fu; Gary G Meadows
Journal:  Oncol Lett       Date:  2011-01-18       Impact factor: 2.967

6.  Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein.

Authors:  Paloma Sanz-Cameno; Samuel Martín-Vílchez; Enrique Lara-Pezzi; María J Borque; Javier Salmerón; Paloma Muñoz de Rueda; José A Solís; Manuel López-Cabrera; Ricardo Moreno-Otero
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

7.  mtDNA mutations increase tumorigenicity in prostate cancer.

Authors:  John A Petros; Amanda K Baumann; Eduardo Ruiz-Pesini; Mahul B Amin; Carrie Qi Sun; John Hall; SoDug Lim; Muta M Issa; W Dana Flanders; Seyed H Hosseini; Fray F Marshall; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

8.  Expression of vascular endothelial growth factor in follicular cell-derived lesions of the thyroid: Is NIFTP benign or precancerous?

Authors:  Neslihan Kurtulmuş; Fatma Tokat; Mete Düren; Hakan Kaya; Burak Ertaş; Ümit İnce
Journal:  Turk J Surg       Date:  2022-03-28

9.  Why targeted therapy hasn't worked in advanced cancer.

Authors:  Jack L Arbiser
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

10.  Formation of Mitochondrial Genome Concatemers as an Alternative Mechanism Promoting Oncogenic Transformation of Lymphoid Cells.

Authors:  Felipe Bedoya; Peter G Medveczky
Journal:  Biosci Hypotheses       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.